Skip to main content
. 2023 Apr 24;29(6):1437–1447. doi: 10.1038/s41591-023-02326-3

Extended Data Table 1.

Adverse Events Reported in at Least Three Patients* Receiving MAPTRx According to Treatment Group

graphic file with name 41591_2023_2326_Tab1_ESM.jpg

*Patients reporting more than one adverse event were counted only once for the incidence using the most severe grade and, if there was a missing severity for the same subject, then the non-missing severity, if available, was chosen for the same subject.

**All headache events including those related to lumbar puncture procedure.